报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | 2.6% | 64.56% | -27.98% | 28/131 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
2024-12-31 | 3.61% | -2.43% | -19.96% | 70/131 | 3.1% | 迈瑞医疗 | 31.95% | 行业排名> |
2024-09-30 | 4.51% | 21.89% | 53.92% | 61/131 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 2.93% | 34.4% | 85.44% | 63/131 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 1.58% | -0.63% | -57.3% | 60/131 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 3.7% | -45.19% | 0% | 75/131 | 5.12% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 3.7% | -39.64% | 69.72% | 74/131 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 2.18% | -35.69% | 37.11% | 78/131 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 1.59% | -29.96% | -76.44% | 72/131 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 6.75% | -61.01% | 10.11% | 84/131 | 13.36% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 6.13% | -58.61% | 80.83% | 79/131 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 3.39% | -65.05% | 49.34% | 81/131 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 2.27% | 2% | -86.89% | 65/131 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 17.31% | 3.22% | 16.88% | 46/131 | 17.4% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 14.81% | 2% | 52.68% | 38/131 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 9.7% | 32.88% | -42.16% | 45/131 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2020-12-31 | 16.77% | -12.11% | 129.73% | 58/131 | 25.69% | 热景生物 | 57.63% | 行业排名> |
2020-06-30 | 7.3% | -17.42% | -61.74% | 56/131 | 15.16% | 中红医疗 | 168% | 行业排名> |
2019-12-31 | 19.08% | 4.61% | 4.61% | 42/131 | 14.38% | 圣湘生物 | 112.46% | 行业排名> |
2018-12-31 | 18.24% | 49.26% | 49.26% | 37/131 | 12.98% | 博拓生物 | 108.13% | 行业排名> |
2017-12-31 | 12.22% | -32.86% | 38.24% | 57/131 | 13.82% | 圣湘生物 | 29.33% | 行业排名> |
2016-06-30 | 8.84% | -23.26% | -51.43% | 13/131 | 6.26% | 健尔康 | 84.09% | 行业排名> |
2015-12-31 | 18.2% | 2% | 57.99% | 19/131 | 15.95% | 祥生医疗 | 28.56% | 行业排名> |
2015-06-30 | 11.52% | 2% | 2% | 10/131 | 7.77% | 心脉医疗 | 31.04% | 行业排名> |